Related references
Note: Only part of the references are listed.Physical Principles of Nanoparticle Cellular Endocytosis
Sulin Zhang et al.
ACS NANO (2015)
Quantitative Assessment of Binding Affinities for Nanoparticles Targeted to Vulnerable Plaque
Tang Tang et al.
BIOCONJUGATE CHEMISTRY (2015)
CD19-Targeted Nanodelivery of Doxorubicin Enhances Therapeutic Efficacy in B-Cell Acute Lymphoblastic Leukemia
Vinu Krishnan et al.
MOLECULAR PHARMACEUTICS (2015)
An in silicoanalysis of nanoparticle/cell diffusive transfer: Application to nano-artificial antigen-presenting cell:T-cell interaction
Michael Labowsky et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Nicolas Bertrand et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Endocytosis and exocytosis of nanoparticles in mammalian cells
Nuri Oh et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Precise Quantification of Nanoparticle Internalization
Claudia Gottstein et al.
ACS NANO (2013)
Exocytosis of nanoparticles from cells: Role in cellular retention and toxicity
Ramin Sakhtianchi et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2013)
Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis
Andrew L. Rankin et al.
JOURNAL OF IMMUNOLOGY (2013)
Antibody Conjugated PLGA Nanoparticles for Targeted Delivery of Paclitaxel Palmitate: Efficacy and Biofate in a Lung Cancer Mouse Model
Nour Karra et al.
SMALL (2013)
The endocytosis and intracellular fate of nanomedicines: Implication for rational design
Longfa Kou et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
Nora Graf et al.
ACS NANO (2012)
Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
Matthias T. Stephan et al.
BIOMATERIALS (2012)
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Jeffrey Hrkach et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles
Hai Wang et al.
BIOMATERIALS (2011)
An Artificial Antigen-presenting Cell with Paracrine Delivery of IL-2 Impacts the Magnitude and Direction of the T Cell Response
Erin R. Steenblock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies
Tore-Geir Iversen et al.
NANO TODAY (2011)
Targeting nanoparticles to cancer
M. Wang et al.
PHARMACOLOGICAL RESEARCH (2010)
Effects of endocytosis inhibitors on internalization of human IgG by Caco-2 human intestinal epithelial cells
Koya Sato et al.
LIFE SCIENCES (2009)
Active targeting schemes for nanoparticle systems in cancer therapeutics
James D. Byrne et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer
Bingfeng Sun et al.
BIOMATERIALS (2008)
Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors
Kimberly L. Douglas et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: A comparison of whole monoclonal antibody, Fab' fragments and single chain Fv
Wilson W. K. Cheng et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging
Derek W. Bartlett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Targeting of nanoparticles to the clathrin-mediated endocytic pathway
Oshrat Harush-Frenkel et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
Dmitri B. Kirpotin et al.
CANCER RESEARCH (2006)
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
OC Farokhzad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes
P Sapra et al.
CLINICAL CANCER RESEARCH (2004)
CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells
M Harata et al.
BLOOD (2004)
Specific recognition of macroscopic objects by the cell surface: Evidence for a receptor density threshold revealed by micrometric particle binding characteristics
S Sarda et al.
BIOPHYSICAL JOURNAL (2004)
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
J Panyam et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells
J Panyam et al.
PHARMACEUTICAL RESEARCH (2003)
Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics
M Chorny et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Ligand-targeted therapeutics in anticancer therapy
TM Allen
NATURE REVIEWS CANCER (2002)
Share Paper
